Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 12.09
-0.36 (-2.89%)
Jun 1, 2026, 3:28 PM IST
Nectar Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -2,929 | -1,137 | 49.95 | -241.83 | 250.47 |
Depreciation & Amortization | 228.03 | 623.89 | 607.18 | 591.19 | 569.68 |
Loss (Gain) From Sale of Assets | -114.99 | 0.14 | - | -404.08 | -94.07 |
Loss (Gain) From Sale of Investments | 520.95 | -0.35 | -1.8 | -1.05 | -0.03 |
Loss (Gain) on Equity Investments | 1,634 | - | - | - | - |
Provision & Write-off of Bad Debts | -98.67 | 16.08 | 9.33 | 2.23 | 9.65 |
Other Operating Activities | 2,223 | 271.92 | 893.53 | 610.79 | 859.77 |
Change in Accounts Receivable | 3,160 | - | - | - | - |
Change in Inventory | 2,329 | - | - | - | - |
Change in Accounts Payable | -3,417 | - | - | - | - |
Change in Other Net Operating Assets | -12.27 | 1,920 | 688.67 | 779.26 | -645.42 |
Operating Cash Flow | -3,487 | 1,694 | 2,247 | 1,337 | 950.05 |
Operating Cash Flow Growth | - | -24.59% | 68.11% | 40.68% | 344.38% |
Capital Expenditures | -122.74 | -437.95 | -294.15 | -300.6 | -249.7 |
Sale of Property, Plant & Equipment | 204.58 | 0.08 | - | 797.88 | 397.31 |
Cash Acquisitions | 32.37 | - | - | - | - |
Divestitures | 12,540 | - | - | - | - |
Investment in Securities | -645.37 | - | - | 2.5 | - |
Other Investing Activities | 72.8 | 18.57 | 123.9 | 17.26 | 18.83 |
Investing Cash Flow | 12,081 | -419.3 | -170.25 | 517.04 | 166.44 |
Short-Term Debt Issued | - | 279.97 | - | - | - |
Long-Term Debt Issued | - | - | 4.12 | 0.01 | 1,568 |
Total Debt Issued | - | 279.97 | 4.12 | 0.01 | 1,568 |
Short-Term Debt Repaid | -4,402 | - | -466.94 | -438.58 | -2,063 |
Long-Term Debt Repaid | -1,962 | -815.11 | -720.11 | -652.39 | -10.28 |
Total Debt Repaid | -6,364 | -815.11 | -1,187 | -1,091 | -2,073 |
Net Debt Issued (Repaid) | -6,364 | -535.14 | -1,183 | -1,091 | -505.69 |
Repurchase of Common Stock | -810 | - | - | - | - |
Other Financing Activities | -491.25 | -745.78 | -871.42 | -764.87 | -688.11 |
Financing Cash Flow | -7,665 | -1,281 | -2,054 | -1,856 | -1,194 |
Net Cash Flow | 929.13 | -5.84 | 22.26 | -2.28 | -77.31 |
Free Cash Flow | -3,610 | 1,256 | 1,953 | 1,036 | 700.35 |
Free Cash Flow Growth | - | -35.66% | 88.50% | 47.91% | - |
Free Cash Flow Margin | -3885.51% | 7.52% | 11.59% | 6.80% | 4.20% |
Free Cash Flow Per Share | -16.52 | 5.60 | 8.71 | 4.62 | 3.12 |
Cash Interest Paid | - | 745.78 | 871.42 | 794.87 | 788.1 |
Levered Free Cash Flow | 5,402 | -171.02 | 970.9 | 259.57 | -492.06 |
Unlevered Free Cash Flow | 5,628 | 310.57 | 1,531 | 777.06 | -54.91 |
Change in Working Capital | 2,059 | 1,920 | 688.67 | 779.26 | -645.42 |